Favorable Appendicular Skeletal Muscle Mass Changes in Older Patients With Type 2 Diabetes Receiving GLP-1 Receptor Agonist and Basal Insulin Co-Therapy

Favorable Appendicular Skeletal Muscle Mass Changes in Older Patients With Type 2 Diabetes Receiving GLP-1 Receptor Agonist and Basal Insulin Co-Therapy

Background And Aims: Maintaining appendicular skeletal muscle mass is important for maintaining the quality of life of elderly patients with type 2 diabetes. The possibility of GLP-1 receptor agonists for maintaining appendicular skeletal muscle mass has previously been reported. We investigated cha...

Full description

Bibliographic Details
Main Authors:	Takafumi Osaka, Masahide Hamaguchi, Michiaki Fukui
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-04-01
Series:	Clinical Medicine Insights: Endocrinology and Diabetes
Online Access:	https://doi.org/10.1177/11795514231161885

Similar Items

Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
by: Rodrigo Oliveira Moreira, et al.
Published: (2018-04-01)

The role of basal insulin and GLP-1 receptor agonist combination products in the management of type 2 diabetes
by: Taylor R. Inman, et al.
Published: (2018-05-01)

A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products
by: Wesley Nuffer, et al.
Published: (2018-03-01)

Effect of Teriparatide on Bone Mineral Density and Trabecular Bone Score in Type 2 Diabetic Patients with Osteoporosis: A Retrospective Cohort Study
by: Chihiro Munekawa, et al.
Published: (2022-03-01)

Free Versus Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor Agonists in Type 2 Diabetes Uncontrolled With GLP-1 Receptor Agonists: A Systematic Review and Indirect Treatment Comparison
by: Han Na Jung, et al.
Published: (2022-05-01)

Economic perspectives for effective control of diabetes mellitus type 2 with fixed combination of basal insulin analog and GLP-1 agonist
by: S. K. Zyryanov, et al.
Published: (2019-10-01)

GLP‑1 receptor agonist protects palmitate-induced insulin resistance in skeletal muscle cells by up-regulating sestrin2 to promote autophagy
by: Xue Tian, et al.
Published: (2023-06-01)

Prediabetes is associated with loss of appendicular skeletal muscle mass and sarcopenia
by: Shuying Li, et al.
Published: (2023-03-01)

Development and Validation of Estimation Equations for Appendicular Skeletal Muscle Mass in Chinese Community-Dwelling Older Adults
by: Sun Y, et al.
Published: (2024-02-01)

Regimen comprising GLP-1 receptor agonist and basal insulin can decrease the effect of food on glycemic variability compared to a pre-mixed insulin regimen
by: Yi-Hsuan Lin, et al.
Published: (2022-12-01)

Usefulness of muscle ultrasound in appendicular skeletal muscle mass estimation for sarcopenia assessment.
by: Seol-Hee Baek, et al.
Published: (2023-01-01)

Effect of Exercise Habit on Skeletal Muscle Mass Varies with Protein Intake in Elderly Patients with Type 2 Diabetes: A Retrospective Cohort Study
by: Yoshitaka Hashimoto, et al.
Published: (2020-10-01)

Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence
by: Meir Schechter, et al.
Published: (2023-05-01)

Association between Lower-to-Upper Ratio of Appendicular Skeletal Muscle and Metabolic Syndrome
by: Hyun Eui Moon, et al.
Published: (2022-10-01)

Appendicular skeletal muscle mass assessment in dogs: a scoping literature review
by: Ah Young Kim, et al.
Published: (2022-07-01)

Fermented soybean foods and diabetes
by: Yoshitaka Hashimoto, et al.
Published: (2023-12-01)

Microbe‐associated metabolites as targets for incident type 2 diabetes
by: Yoshitaka Hashimoto, et al.
Published: (2021-04-01)

Dietary Fiber Intake Is Related to Skeletal Muscle Mass, Body Fat Mass, and Muscle-to-Fat Ratio Among People With Type 2 Diabetes: A Cross-Sectional Study
by: Fuyuko Takahashi, et al.
Published: (2022-05-01)

Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice
by: Ryo Bamba, et al.
Published: (2022-02-01)

Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study
by: Enrico Longato, et al.
Published: (2021-11-01)

Impact of Eating Speed on Muscle Mass in Older Patients With Type 2 Diabetes: A Prospective Study of KAMOGAWA–DM Cohort
by: Genki Kobayashi, et al.
Published: (2022-06-01)

GLP-1 agonists in treatment of obesity
by: Władysław Orłowski, et al.
Published: (2023-01-01)

Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
by: Nik Krajnc, et al.
Published: (2023-07-01)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
by: Marta Seghieri, et al.
Published: (2018-11-01)

Predictors of Responsiveness to GLP-1 Receptor Agonists in Insulin-Treated Patients with Type 2 Diabetes
by: Colleen Gavigan, et al.
Published: (2023-01-01)

Influence of the appendicular skeletal muscle mass index on the bone mineral density of postmenopausal women
by: Geise Ferreira da Cruz, et al.
Published: (2021-10-01)

Development of prediction equations for estimating appendicular skeletal muscle mass in Japanese men and women
by: Taishi Furushima, et al.
Published: (2017-08-01)

Anthropometric characteristics of postmenopausal women depending on appendicular skeletal mass
by: V. Povoroznyuk, et al.
Published: (2014-10-01)

Appendicular Skeletal Muscle Mass and Insulin Resistance in an Elderly Korean Population: The Korean Social Life, Health and Aging Project-Health Examination Cohort
by: Seung Won Lee, et al.
Published: (2015-02-01)

Cutoff values for appendicular skeletal muscle mass and strength in relation to fear of falling among Brazilian older adults: cross-sectional study
by: Ricardo Aurélio Carvalho Sampaio, et al.
Published: (2017-11-01)

Changes in glycemic control and skeletal muscle mass indices after dapagliflozin treatment in individuals with type 1 diabetes mellitus
by: Yuta Yoshimura, et al.
Published: (2023-10-01)

GLP-1 Receptor Agonists and Kidney Protection
by: Eulalia Valentina Greco, et al.
Published: (2019-05-01)

The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome
by: Krzysztof Bednarz, et al.
Published: (2022-04-01)

Role of the Appendicular Skeletal Muscle Index for Predicting the Recurrence-Free Survival of Head and Neck Cancer
by: Kun-Yun Yeh, et al.
Published: (2021-02-01)

Appendicular Skeletal Muscle Mass Index and Physiological Performance in Post-Menopausal Women with Total Thyroidectomy
by: Wei-Lun Wen, et al.
Published: (2021-08-01)

Low appendicular skeletal muscle mass index is associated with the anthropometric variables of post-menopausal women
by: Geise Ferreira da Cruz, et al.
Published: (2022-08-01)

Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults
by: Rahul S. Dadwani, et al.
Published: (2023-07-01)

Massive Axial and Appendicular Skeletal Deformities in Connection with Gorham-Stout Syndrome
by: Ali Al Kaissi, et al.
Published: (2019-05-01)

Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study
by: Aya Kitae, et al.
Published: (2021-05-01)

External validation of BIA equations to estimate appendicular skeletal muscle mass in older adults: Importance of the bias analysis and derivation of correction factors to achieve agreement
by: María Cáñez-Ríos, et al.
Published: (2022-08-01)